Kinesio Taping in Sit to Stand Movement fo Cerebral Palsy

Imediate Effects of Kinesio Tapin in Muscle Activity and Time to Perform Sit to Stand Movement in Children With Cerebral Palsy

Children with Cerebral Palsy (CP) present limited performance of functional activities and activities of daily life. Kinesio taping has been definied as a promising technique for children with CP ans has been extensively used in clinical practice. However, several studies have found a low level of evidence of its effectiveness in healthy individuals. We aim to evaluate the effects of the immediate application of Kinesio taping on the activation of the rectus femoris and anterior tibialis muscles and on the duration of sit-to-stand movement in children with CP.

Study Overview

• Status: Completed
• Conditions: Cerebral Palsy
• Intervention / Treatment: Other: Kinesio taping; Other: Without taping

• Study Type: Interventional
• Enrollment (Actual): 25
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Brazil
  • Santa Catarina
    • Araranguá, Santa Catarina, Brazil, 88.906-072
      • Universidade Federal de Santa Catarina

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 5 years to 18 years (ADULT, CHILD)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• diagnosed with spastic CP
• aged from 5 to 18 years
• Gross Motor Function Classification System levels I and II
• able to understand simple commands
• able to perform the sit-to-stand movement without support

Exclusion Criteria:

• muscle shortening in hamstring, gastrocnemius and hip flexors
• deformities in the lower limbs such as fixed hip and knee flexion that could compromise the sit-to-stand movement
• surgical procedures in the lower limbs and trunk in the previous 12 months
• botulinum toxin injection in the previous 6 months

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: NON_RANDOMIZED
• Interventional Model: CROSSOVER
• Masking: SINGLE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
OTHER: First test; All measures were evaluated	Other: Kinesio taping; An experienced physiotherapist placed the base of the Kinesio taping strip, over rectus femoris muscle, 3cm bellow the anterior iliac spine, without tension. From this point, the Kinesio taping was placed up to the upper edge of the patella and stretched to 100% tension. It was, then, bi-sectioned, circled the patella and ended in the tuberosity of the femur, without tension. In order to avoid interference in the electromyography signals, a section was held at Kinesio taping at the point where the electrode was placed.; Other: Without taping; Children performed functional activities without tape
OTHER: Second test; All measures were evaluated	Other: Kinesio taping; An experienced physiotherapist placed the base of the Kinesio taping strip, over rectus femoris muscle, 3cm bellow the anterior iliac spine, without tension. From this point, the Kinesio taping was placed up to the upper edge of the patella and stretched to 100% tension. It was, then, bi-sectioned, circled the patella and ended in the tuberosity of the femur, without tension. In order to avoid interference in the electromyography signals, a section was held at Kinesio taping at the point where the electrode was placed.; Other: Without taping; Children performed functional activities without tape

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Muscle activity	An electromyography analysis was performed to evaluate the rectus femoris and tibialis anterior activity during the sit-to-stand movement and the five time sit-to-stand test. Electrodes were placed in both lower limbs. Mean root mean square (mRMS) values were used for statistical analysis. Mean root mean square values were normalized by the maximum value of each trial and individual.	on the day of evaluation
Time to perform sit to stand	Children were seated with hip, knee and ankle flexed at 90°. Both feet were symmetrically positioned shoulder width apart and arms were crossed over the chest. Children should get up from the seat after the verbal command of the evaluator. Children performed the sit-to-stand movement at a speed that simulated the one usually adopted in daily routine	on the day of evaluation
Time to perform five time sit-to-stand test	Children had to get up and sit down five times as fast as possible. The instructions before starting the test were: "Stand up and sit down as quickly as possible for 5 times. The test will be finished when you return to the seated position the 5th time. Continue the sit-to-stand movement until I ask you to stop. If you try but cannot stand up, just let me know. Ready? go!"	on the day of evaluation

Collaborators and Investigators

• Sponsor: Universidade Federal de Santa Catarina

Study record dates

Study Major Dates

• Study Start (ACTUAL): April 1, 2016
• Primary Completion (ACTUAL): August 30, 2017
• Study Completion (ACTUAL): December 30, 2017

Study Registration Dates

• First Submitted: January 11, 2018
• First Submitted That Met QC Criteria: January 11, 2018
• First Posted (ACTUAL): January 18, 2018

Study Record Updates

• Last Update Posted (ACTUAL): January 18, 2018
• Last Update Submitted That Met QC Criteria: January 11, 2018
• Last Verified: January 1, 2018

More Information

Terms related to this study

• Keywords: children; intervention
• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Brain Damage, Chronic; Cerebral Palsy
• Other Study ID Numbers: UFSC-SIGPEX / 201702940

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: De-identified individual participant data for all primary and secondary outcome measures will be available
• IPD Sharing Time Frame: Data will be available within one year of study completion
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; SAP; ICF; ANALYTIC_CODE; CSR

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No